| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |